XT
PALI icon

XTX Topco’s Palisade Bio PALI Stock Holding History

XTX Topco’s Portfolio PALI Stock Details PALI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$272K Sell
130,263
-74,327
-36% -$146K ﹤0.01% 3009
2026
Q1 		$358K Buy
204,590
+182,921
+844% +$333K 0.01% 2329
2025
Q4 		$50.9K Buy
21,669
+7,584
+54% +$14.6K ﹤0.01% 2828
2025
Q3 		$12.1K Sell
14,085
-13,252
-48% -$10.4K ﹤0.01% 2418
2025
Q2 		$18.6K Buy
+27,337
New +$19.6K ﹤0.01% 2176

Other funds holding PALI

SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BGI
B Group Inc Dallas, Texas $213M AUM 96.05% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

XTX Topco's PALI Position: Q2 2026 in Review

XTX Topco reduced its Palisade Bio (PALI) stake by 36% in Q2 2026, selling an estimated $146K and leaving 130,263 shares worth $272K. The position accounts for ﹤0.01% of the portfolio, ranked #3009.

XTX Topco first reported a position in PALI in Q2 2025 and has held it in 5 quarters since. The position peaked at $358K in Q1 2026. 124 funds tracked by Wall St. Rank hold PALI as of Q2 2026.

  • XTX Topco held 130,263 shares of Palisade Bio worth $272K as of Q2 2026.
  • XTX Topco sold 74,327 Palisade Bio shares in Q2 2026, an estimated $146K.
  • Palisade Bio made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #3009 holding.
  • XTX Topco first reported a position in Palisade Bio in Q2 2025 and has held it in 5 quarters since.
  • XTX Topco's Palisade Bio position peaked at $358K in Q1 2026.
  • 124 funds tracked by Wall St. Rank held Palisade Bio as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.